Skip to main content
Top
Published in: Diseases of the Colon & Rectum 6/2004

01-06-2004 | Original Contribution

Depletion of Circulating Insulin-Like Growth Factor Binding Protein 3 After Open Surgery is Associated With High Interleukin-6 Levels

Authors: Irena Kirman, M.D., Ph.D., Natalia Poltaratskaia, M.S., Vesna Cekic, R.N., Kenneth A. Forde, M.D., Parswa Ansari, M.D., Catherine Boulay, M.D., Richard L. Whelan, M.D.

Published in: Diseases of the Colon & Rectum | Issue 6/2004

Login to get access

PURPOSE:

We have previously shown that plasma from open, but not laparoscopic-assisted, surgery patients has increased mitogenic activity for colon cancer cells. Decreased insulin-like growth factor binding protein 3 levels, most likely the result of an open surgery-induced proteolytic activity, may account for this finding. Plasma proteases are activated by interleukin-6. This study was designed to investigate plasma insulin-like growth factor binding protein 3 and interleukin-6 levels after major open or laparoscopic-assisted surgery.

METHODS:

EDTA plasma was obtained from 24 patients undergoing resection for colonic adenocarcinoma. Insulin-like growth factor binding protein 3 was detected by Western blot analysis and enzyme-linked immunosorbent assay. Interleukin-6 levels were determined by enzyme-linked immunosorbent assay. The effect of insulin-like growth factor binding protein 3 on tumor growth was tested using HCT116 cells.

RESULTS:

In patients undergoing open surgery, enzyme-linked immunosorbent assay revealed a significant decrease in total insulin-like growth factor binding protein 3 levels on postoperative Day 1 (915.6 ± 378.5 ng/ml) compared with preoperative levels (1,267.5 ± 407.9 ng/ml; P < 0.001). Western blots revealed a decrease in the levels of intact insulin-like growth factor binding protein 3. In patients undergoing laparoscopic-assisted surgery, levels of total and intact insulin-like growth factor binding protein 3 before surgery (1,088.9 ± 232.5 ng/ml) and on postoperative Day 1 (1,202.3 ± 285.6 ng/ml) were comparable with no significant changes in Western blot analysis. Interleukin-6 levels were undetectable preoperatively. On postoperative Day 1, interleukin-6 concentration was higher in open surgery group (434.8 ± 506.6 pg/ml) compared with laparoscopic-assisted surgery group (100.9 ± 60.2 pg/ml; P < 0.0001), and correlated significantly with a decrease in plasma insulin-like growth factor binding protein 3 after open surgery (r = 0.81; P < 0.0001).

CONCLUSIONS:

A significant decrease in both total and free insulin-like growth factor binding protein 3 occurs after open but not laparoscopic colectomy. There is an associated increase in the levels of interleukin-6. It remains to be proven that the interleukin-6 elevations are responsible for the low insulin-like growth factor binding protein 3 level seen after open surgery.
Literature
1.
go back to reference Braga, M, Vignali, A, Gianotti, L, et al. 2002Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcomeAnn Surg23675966 Braga, M, Vignali, A, Gianotti, L,  et al. 2002Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcomeAnn Surg23675966
2.
go back to reference Kirman, I, Cekic, V, Poltaratskaia, N, et al. 2002Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein 3 levels may, in part, account for this changeSurgery13218692 Kirman, I, Cekic, V, Poltaratskaia, N,  et al. 2002Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein 3 levels may, in part, account for this changeSurgery13218692
3.
go back to reference Cubbage, ML, Suwanichkul, A, Powell, DR 1990Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activityJ Biol Chem265126429 Cubbage, ML, Suwanichkul, A, Powell, DR 1990Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activityJ Biol Chem265126429
4.
go back to reference Lewitt, MS, Saunders, H, Phuyal, JL, Baxter, RC 1994Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient ratsEndocrinology13424049 Lewitt, MS, Saunders, H, Phuyal, JL, Baxter, RC 1994Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient ratsEndocrinology13424049
5.
go back to reference Valentinis, B, Bhala, A, DeAngelis, T, Baserga, R, Cohen, P 1995The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor geneMol Endocrinol93617 Valentinis, B, Bhala, A, DeAngelis, T, Baserga, R, Cohen, P 1995The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor geneMol Endocrinol93617
6.
go back to reference Hong, J, Zhang, G, Dong, F, Rechler, MM 2002Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cellsJ Biol Chem2771048997 Hong, J, Zhang, G, Dong, F, Rechler, MM 2002Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cellsJ Biol Chem2771048997
7.
go back to reference Booth, BA, Boes, M, Bar, RS 1996IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragmentsAm J Physiol271E46570 Booth, BA, Boes, M, Bar, RS 1996IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragmentsAm J Physiol271E46570
8.
go back to reference Durham, SK, Suwanichkul, A, Hayes, JD, Herington, AC, Powell, DR, Campbell, PG 1999The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysisHorm Metab Res3121625 Durham, SK, Suwanichkul, A, Hayes, JD, Herington, AC, Powell, DR, Campbell, PG 1999The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysisHorm Metab Res3121625
9.
go back to reference Cohen, P, Peehl, DM, Graves, HC, Rosenfeld, RG 1994Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 proteaseJ Endocrinol14240715 Cohen, P, Peehl, DM, Graves, HC, Rosenfeld, RG 1994Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 proteaseJ Endocrinol14240715
10.
go back to reference Claussen, M, Kubler, B, Wendland, M, et al. 1997Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin DEndocrinology1383797803 Claussen, M, Kubler, B, Wendland, M,  et al. 1997Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin DEndocrinology1383797803
11.
go back to reference Lemmey, A, Maddison, P, Breslin, A, et al. 2001Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritisJ Rheumatol282934 Lemmey, A, Maddison, P, Breslin, A,  et al. 2001Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritisJ Rheumatol282934
12.
go back to reference Benedetti, F, Meazza, C, Oliveri, M, et al. 2001Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritisEndocrinology142481826 Benedetti, F, Meazza, C, Oliveri, M,  et al. 2001Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritisEndocrinology142481826
13.
go back to reference Grimberg, A, Liu, B, Bannerman, P, El-Deiry, WS, Cohen, P 2002IGFBP-3 mediates p53-induced apoptosis during serum starvationInt J Oncol2132735 Grimberg, A, Liu, B, Bannerman, P, El-Deiry, WS, Cohen, P 2002IGFBP-3 mediates p53-induced apoptosis during serum starvationInt J Oncol2132735
14.
go back to reference Rajah, R, Valentinis, B, Cohen, P 1997Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanismJ Biol Chem272121818 Rajah, R, Valentinis, B, Cohen, P 1997Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanismJ Biol Chem272121818
15.
go back to reference Leung, KL, Lai, PB, Ho, RL, et al. 2000Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: a prospective randomized trialAnn Surg23150611 Leung, KL, Lai, PB, Ho, RL,  et al. 2000Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: a prospective randomized trialAnn Surg23150611
16.
go back to reference Groof, F, Joosten, KF, Janssen, JA, et al. 2002Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivorsJ Clin Endocrinol Metab87311824 Groof, F, Joosten, KF, Janssen, JA,  et al. 2002Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivorsJ Clin Endocrinol Metab87311824
17.
go back to reference Raynaud-Simon, A, Perin, L, Meaume, S, et al. 2002IGF-I, IGF-I-binding proteins and GH-binding protein in malnourished elderly patients with inflammation receiving refeeding therapyEur J Endocrinol14665765 Raynaud-Simon, A, Perin, L, Meaume, S,  et al. 2002IGF-I, IGF-I-binding proteins and GH-binding protein in malnourished elderly patients with inflammation receiving refeeding therapyEur J Endocrinol14665765
18.
go back to reference Crown, AL, Cottle, K, Lightman, SL, et al. 2002What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?Clin Endocrinol5672333 Crown, AL, Cottle, K, Lightman, SL,  et al. 2002What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?Clin Endocrinol5672333
19.
go back to reference Benedetti, F, Meazza, C, Martini, A 2002Role of interleukin-6 in growth failure: an animal modelReview. Horm Res58247 Benedetti, F, Meazza, C, Martini, A 2002Role of interleukin-6 in growth failure: an animal modelReview. Horm Res58247
20.
go back to reference Tsujinaka, T, Fujita, J, Ebisui, C, et al. 1996Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic miceJ Clin Invest972449 Tsujinaka, T, Fujita, J, Ebisui, C,  et al. 1996Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic miceJ Clin Invest972449
21.
go back to reference Gerber, A, Wille, A, Welte, T, Ansorge, S, Buhling, F 2001Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cellsJ Interferon Cytokine Res21119 Gerber, A, Wille, A, Welte, T, Ansorge, S, Buhling, F 2001Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cellsJ Interferon Cytokine Res21119
22.
go back to reference Solis-Herruzo, JA, Rippe, RA, Schrum, LW, et al. 1999Interleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblastsJ Biol Chem2743091926 Solis-Herruzo, JA, Rippe, RA, Schrum, LW,  et al. 1999Interleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblastsJ Biol Chem2743091926
23.
go back to reference Yamamoto, M, Ikeda, S, Kondo, H, Inoue, S 2002Design and synthesis of dual inhibitors for matrix metalloproteinase and cathepsinBioorg Med Chem Lett123758 Yamamoto, M, Ikeda, S, Kondo, H, Inoue, S 2002Design and synthesis of dual inhibitors for matrix metalloproteinase and cathepsinBioorg Med Chem Lett123758
24.
go back to reference Baxter, RC 2001Signalling pathways involved in antiproliferative effects of IGFBP-3: a reviewMol Pathol541458 Baxter, RC 2001Signalling pathways involved in antiproliferative effects of IGFBP-3: a reviewMol Pathol541458
25.
go back to reference Yamaguchi, K, Takagi, Y, Aoki, S, Futamura, M, Saji, S 2000Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resectionAnn Surg2325865 Yamaguchi, K, Takagi, Y, Aoki, S, Futamura, M, Saji, S 2000Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resectionAnn Surg2325865
26.
go back to reference Ito, S, Nakanishi, H, Hirai, T, et al. 2002Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCyclerCancer Lett183195203 Ito, S, Nakanishi, H, Hirai, T,  et al. 2002Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCyclerCancer Lett183195203
27.
go back to reference Fanayan S, Firth SM, Butt AJ, Baxter RC. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. J Biol Chem 200015;275:39146–51 Fanayan S, Firth SM, Butt AJ, Baxter RC. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. J Biol Chem 200015;275:39146–51
28.
go back to reference Hong, J, Zhang, G, Dong, F, Rechler, MM 2002Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cellsJ Biol Chem2771048997 Hong, J, Zhang, G, Dong, F, Rechler, MM 2002Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cellsJ Biol Chem2771048997
1.
go back to reference Benedetti, F, Meazza, C, Oliveri, M, et al. 2001Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritisEndocrinology142481826 Benedetti, F, Meazza, C, Oliveri, M,  et al. 2001Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritisEndocrinology142481826
2.
go back to reference Kirman, I, Cekic, V, Poltaratskaia, N, et al. 2002Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein 3 levels may, in part, account for this changeSurgery13218692 Kirman, I, Cekic, V, Poltaratskaia, N,  et al. 2002Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein 3 levels may, in part, account for this changeSurgery13218692
3.
go back to reference Fanayan S, Firth SM, Butt AJ, Baxter RC. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. J Biol Chem 200015;275:39146–51 Fanayan S, Firth SM, Butt AJ, Baxter RC. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. J Biol Chem 200015;275:39146–51
4.
go back to reference Hong, J, Zhang, G, Dong, F, Rechler, MM 2002Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cellsJ Biol Chem2771048997 Hong, J, Zhang, G, Dong, F, Rechler, MM 2002Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cellsJ Biol Chem2771048997
Metadata
Title
Depletion of Circulating Insulin-Like Growth Factor Binding Protein 3 After Open Surgery is Associated With High Interleukin-6 Levels
Authors
Irena Kirman, M.D., Ph.D.
Natalia Poltaratskaia, M.S.
Vesna Cekic, R.N.
Kenneth A. Forde, M.D.
Parswa Ansari, M.D.
Catherine Boulay, M.D.
Richard L. Whelan, M.D.
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 6/2004
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-004-0512-4

Other articles of this Issue 6/2004

Diseases of the Colon & Rectum 6/2004 Go to the issue

OriginalPaper

Announcements

Letter to the Editor

The Author Replies